Sakura Pathology Award
2026-03-10 05:35:18
The 18th Sakura Pathology Technology Award Recipients Announced for Contributions to Pathology Advancements
The 18th Sakura Pathology Technology Award Recipients Announced
Sakura FineTech Japan Co., Ltd., headquartered in Chuo-ku, Tokyo, has announced the recipients of the 18th Sakura Pathology Technology Award. This award, established to recognize outstanding contributions to the field of pathology, has been serving to promote advancements in pathology and medical diagnostics since 2008.
Importance of Pathology in Modern Medicine
As the medical field rapidly evolves, the role of pathology in providing final diagnoses for cancer has become increasingly critical. The demand for high-quality pathology specimens is paramount in accurate diagnostics, and achieving this requires advances in automation, instrumentation, reagents, and the nurturing of skills passed down from experienced technicians to new professionals.
The Sakura Pathology Technology Award applauds those involved in pathology-related activities, ranging from academic research to community engagement and mentoring. This year, the award committee, consisting of prominent experts in pathology diagnosis, has made its selections for the award recipients.
Recipients of the 18th Sakura Pathology Technology Award
Encouragement Award
Recipient: Tamihiro Nagatani
Affiliation: Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Position: Clinical Genetics Department, Himeji Red Cross Hospital
Reason for Award:
Tamihiro Nagatani has established innovative techniques for preparing pathology specimens tailored for cancer gene panel testing, crucial for small tissue samples from endoscopies and biopsies. This development aims to enhance the success rate of genomic analyses. Furthermore, he actively conducts workshops and study sessions in collaboration with local medical institutions to disseminate his techniques, greatly contributing to regional medical education and the advancement of pathology practices nationwide.
Rookie Award
Recipient: Yuki Kurita
Affiliation: Hamamatsu University School of Medicine, Advanced Photomedicine Research Center
Reason for Award:
Yuki Kurita has developed an AI tool, “CYTOLONE,” to support cytology diagnosis, acknowledging the importance of quality in pathology work. This tool operates without specialized equipment and suggests additional tests needed for effective differential diagnoses, thereby improving workflow and fostering uniformity in techniques across pathology practices. In addition, he leads student groups to promote AI and information sciences, ensuring the cultivation of future clinical laboratory technicians, positioning him as a key figure in fostering the next generation of medical talent.
Overview of the Sakura Pathology Technology Award
The Sakura Pathology Technology Award aims to inspire people working in pathology and related fields, encouraging improvements in pathology practices and education. Award categories include published research on specimen preparation techniques, technical advancements in daily operations, mentoring new technicians, and significant contributions to community healthcare.
With the growing recognition of pathology diagnostics and the increasing needs of clinical practice and patients, Sakura FineTech Japan is committed to continuing support and contribution to progress in pathology through this award program.
Selection Criteria and Process
Candidates for the award include pathology technicians, researchers, and their organizations. The selection committee, comprised of leading experts in pathology and medicine, evaluates nominees based on their research, community efforts, and contributions to education in the field.
About Sakura FineTech Japan Co., Ltd.:
Sakura FineTech Japan Co., Ltd. is a subsidiary of Sakura Global Holdings Inc., specializing in pathology-related instruments, consumables, and reagents. The company plays a vital role in delivering significant advancements in pathology diagnostics, particularly emphasizing their importance as the final arbiter of diagnoses in medical practice.